Chief Medical Officer

Dr. Javad Shahidi, MD, MSc, serves as Chief Medical Officer at Centessa Pharmaceuticals. In the past 10+ years, Javad has held increasing responsibilities in Clinical Development at Bayer, Eli Lilly and Company and Daiichi Sankyo. Most recently, he led the development of ENHERTU® from its first-in-human studies through its rapid expansion leading to several regulatory submissions and approvals around the world.

Javad earned his MD in Tehran and his MSc in Experimental Medicine from McGill University in Montreal.